Last updated on August 2019

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A


Brief description of study

The primary purpose of the study is to compare the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II -IIIA and the subset of IIIB (T>5cm N2 disease) completely resected (R0) non-small cell lung cancer (NSCLC).

Clinical Study Identifier: NCT03447769

Find a site near you

Start Over

Novartis Investigative Site

El Metn, Lebanon
2.49miles
  Connect »

Novartis Investigative Site

Ashrafieh, Lebanon
5.02miles
  Connect »

Novartis Investigative Site

Beirut, Lebanon
5.94miles
  Connect »